The CDC estimates 19,000,000 illnesses, 250,000 hospitalizations, and 10,000 deaths due to flu this season.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
(CIDRAP News) While the US influenza season has started slowly, cases are surging in England, raising concern that the country could have its toughest season since 1999-2000.
(CIDRAP News) Cost issues and the risk of viral resistance drew considerable attention today in an online presentation by federal health officials on their revised guidance regarding use of antiviral drugs in an influenza pandemic.
The Department of Health and Human Services (HHS) released two guidance documents this week, one on antiviral use in general and one on employer stockpiling of antivirals.
Editor's note: This story was revised Dec 17 to include an item that was mistakenly left out of the list of five main recommendations on antiviral use in a pandemic.
(CIDRAP News) With this year's US influenza epidemic barely getting started, there are already signs of increased viral resistance to oseltamivir (Tamiflu), the most widely used antiviral drug, the Centers for Disease Control and Prevention (CDC) said today.
In its flu surveillance report for Nov 30 to Dec 6, released today, the CDC said 45 of 46 influenza A/H1N1 viruses tested so far have shown resistance to oseltamivir.
(CIDRAP News) The Rand Corp. today released its first-ever midseason survey on the uptake of the current influenza vaccine, which found that public officials still have a tall task in front of them to administer this year's record vaccine supply.
The survey indicated that about 30% of US adults had received a flu shot by mid November, but more than half of those surveyed said they didn't plan to get the immunization.
Editor's Note: CIDRAP's Public Health Practices online database showcases peer-reviewed practices, including useful tools to help others with their planning. This article is one of a series exploring the development of these practices. We hope that describing the process and context of these practices enhances pandemic planning.
(CIDRAP News) Hospital workers who followed official infection control guidelines for pandemic influenza for 1 day used 10 times as many gloves as usual, generated three times as much clinical waste, and found that many tasks took longer than normal, according to a new report.
(CIDRAP News) A Canadian study raises questions about the value of formal "fit testing" for the respirators worn by healthcare workers to protect them from airborne pathogens, suggesting that it does little good for workers who don't routinely wear the devices.
(CIDRAP News) Millions of people who use the Internet to look for information about influenza provide the fuel for a system launched by Google this week to estimate flu activity day by day in the United States.
(CIDRAP News) A 15-year-old Indonesian girl from central Java recently died from an H5N1 avian influenza infection, according to news reports that cited a local health official and a physician who treated the girl.
